EPISODE · Oct 13, 2025 · 21 MIN
Veru's CEO Mitch Steiner on Enobosarm's value-added to the booming GLP-1 Weight Loss Drug Market
Send us Fan MailWe welcome back Veru's CEO Mitch Steiner to our latest WTR Small-Cap Spotligh podcast. In this podcast, Steiner gives us his thoughts on the latest trends in the rapidly evolving GLP-1 market for weight loss, discusses the data from enobosarm's Phase 2b data, and explains Veru's obesity drug development strategy in the wake of its recent positive interactions with the FDA.
Embed this episode
Ready to play
Veru's CEO Mitch Steiner on Enobosarm's value-added to the booming GLP-1 Weight Loss Drug Market
0:00
21:35
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of WTR Small-Cap Spotlight?
This episode is 21 minutes long.
When was this WTR Small-Cap Spotlight episode published?
This episode was published on October 13, 2025.
Can I download this WTR Small-Cap Spotlight episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!